According to a news report published on medicinenet.com, a new study shows that regular use of proton pump inhibitors (PPIs) could increase the risk of developing type 2 diabetes. The new study was published by Chinese researchers who examined data collected by over 200,000 U.S. health care professionals. The researchers discovered that those patients who were […]
Regular use of PPIs increase risk of diabetes
According to a news report published on medicinenet.com, a new study shows that regular use of proton pump inhibitors (PPIs) could increase the risk of developing type 2 diabetes. The new study was published by Chinese researchers who examined data collected by over 200,000 U.S. health care professionals. The researchers discovered that those patients who were regular users of PPIs had a 24% greater chance of developing type 2 diabetes. The Chinese researchers also discovered that the longer patients used PPI medications, the greater their chances of developing diabetes.
The study was not intended to prove PPIs cause type 2 diabetes. It can only show a link between the two. Researchers are recommending that patients who are taking PPIs for an extended period of time should regularly monitor their blood sugar for changes that might indicate pre-diabetes. In addition to finding a link between the regular use of PPIs with an increased risk of developing type 2 diabetes, the study’s researchers found that long-term PPI usage increased the odds of developing type 2 diabetes. According to the study, those study participants who took PPIs for two years had a 5% increased risk of developing type 2 diabetes, while study participants who took PPIs for two or more years saw an increased risk of 26%.
The study also stated that when the study participants stopped taking PPIs, their risk of developing type 2 diabetes dropped, and continued to drop the longer the participant stopped taking their PPI medication.
The Chinese study also discovered a 14% increased risk of type 2 diabetes in patients who were taking another kind of heartburn medication called H2 receptor blockers, such as Tagamet, Pepcid, Zantac.
Researchers are unsure how taking acid-reducing medications can increase a patient’s diabetes risk. The report suggests that the link between PPIs and type 2 diabetes might be due to a change in the body’s natural bacteria balance. More research is necessitated to answer these and other important health questions.
PPIs are one of the most consumed drugs worldwide. Proton pump inhibitors (PPIs) are available by over-the-counter or prescription and are taken to treat heartburn symptoms, peptic ulcers, acid reflux, and other digestive conditions. The most commonly used Proton pump inhibitors, include Aciphex, Nexium, Prilosec, Prevacid, and Protonix. Long-term consumption of PPIs have also been linked to an increased risks of kidney disease, bone fractures, stomach cancer, and serious digestive tract infections. Please visit our PPI Injury Claims page for additional information about filing a claim regarding those injuries.
Parker Waichman LLP helps those who have been harmed by a dangerous medication receive full monetary compensation. Trust your case with our product liability lawyers. For a free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).
